2024-03-28T16:57:28Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_5BADFEE13999
2024-03-23T02:25:17Z
openaire
documents
urnserval
serval:BIB_5BADFEE13999
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma.
10.1038/sj.bjc.6603166
000238288000002
16685263
Buchegger
F.
author
Antonescu
C.
author
Delaloye
A.B.
author
Helg
C.
author
Kovacsovics
T.
author
Kosinski
M.
author
Mach
J.P.
author
Ketterer
N.
author
article
2006
British journal of cancer
0007-0920
journal
94
12
1770-1776
Adult
Aged
Antibodies, Monoclonal
Antineoplastic Agents
Disease-Free Survival
Female
Humans
Lymphoma, Non-Hodgkin
Male
Middle Aged
Neoplasm Recurrence, Local
Survival Analysis
Survival Rate
Time
Treatment Outcome
eng
60_published
true
peer-reviewed
Publication types: Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_5BADFEE13999
https://serval.unil.ch/resource/serval:BIB_5BADFEE13999.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5BADFEE139999
Copying allowed only for non-profit organizations